Cross-talk between ILC2 and Gata3high Tregs locally constrains adaptive type 2 immunity.
Saved in:
| Title: | Cross-talk between ILC2 and Gata3high T |
|---|---|
| Authors: | Stockis J; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Yip T; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Moreno-Vicente J; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Burton O; Immunology Programme, Babraham Institute, Cambridge CB22 3AT, UK.; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK., Samarakoon Y; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Schuijs MJ; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Raghunathan S; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Garcia C; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Luo W; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Whiteside SK; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK., Png S; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Simpson C; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Monk S; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Sawle A; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Yin K; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Barbieri J; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Papadopoulos P; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Wong H; Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK., Rodewald HR; Division of Cellular Immunology, German Cancer Research Center, Heidelberg 69120, Germany., Vyse T; Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK., McKenzie ANJ; Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK., Cragg MS; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK., Hoare M; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.; Early Cancer Institute, Hutchison Research Centre, University of Cambridge, Cambridge CB2 0XZ, UK., Withers DR; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK., Fehling HJ; Institute of Immunology, University Hospital Ulm, Ulm 89081, Germany., Roychoudhuri R; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK., Liston A; Immunology Programme, Babraham Institute, Cambridge CB22 3AT, UK.; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK., Halim TYF; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. |
| Source: | Science immunology [Sci Immunol] 2024 Jul 19; Vol. 9 (97), pp. eadl1903. Date of Electronic Publication: 2024 Jul 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2470-9468 |
|---|---|
| DOI: | 10.1126/sciimmunol.adl1903 |
